Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,537 | 6,250 | 8,236 | 4,085 | 4,359 |
| Marketable Securities | 495 | 463 | 473 | 468 | 499 |
| TOTAL | $4,518 | $6,796 | $8,898 | $5,214 | $5,798 |
| Non-Current Assets | |||||
| PPE Net | 5 | 6 | 4 | 4 | 5 |
| Investments And Advances | 0 | 0 | 0 | 11 | 0 |
| Other Non-Current Assets | 38 | 67 | 96 | 124 | 151 |
| TOTAL | $43 | $73 | $99 | $139 | $157 |
| Total Assets | $4,561 | $6,869 | $8,997 | $5,353 | $5,955 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 997 | 758 | 1,053 | 1,555 | 1,806 |
| Accrued Expenses | 223 | 1,241 | 296 | 524 | 700 |
| TOTAL | $1,434 | $2,119 | $1,379 | $2,187 | $2,506 |
| Non-Current Liabilities | |||||
| Long Term Debt | 31 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 124 | 214 | 137 | 31 |
| TOTAL | $31 | $124 | $214 | $137 | $31 |
| Total Liabilities | $1,465 | $2,243 | $1,593 | $2,324 | $2,536 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9 | 9 | 8 | 8 | 6 |
| Common Shares | 2 | 1 | 1 | 1 | 1 |
| Retained earnings | -269,768 | -246,020 | -243,190 | -240,970 | -238,823 |
| Other shareholders' equity | 0 | 0 | 1 | 2 | -1 |
| TOTAL | $3,096 | $4,626 | $7,404 | $3,029 | $3,419 |
| Total Liabilities And Equity | $4,561 | $6,869 | $8,997 | $5,353 | $5,955 |